France: Ambler completes its Series A round of funding

0
3


A few months after it raised €1.5 m(US$1.7 m), French health transport startup Ambler, has completed a €6m round of Series A funding with Bpifrance, via the Digital Venture of the division, Idinvest Partners, Partech and Kima Ventures in order to accelerate the development of its platform.

“The completion of this Series A round will enable us, together, with the trust of the investors, to accelerate the achievement of our vision for Ambler to become the largest network of ambulance services in France, bringing together thousands of small and medium-sized ambulance companies, using an innovative model of partnership and our technology to improve the level of service to the highest standards of mobility,” said Mehdi Ben Abroug, co-founder and ceo of Ambler.

In France, non-emergency medical transport market represents 80 million trips per year and is worth 5 billion euros, which is more than the taxi and VTC sectors.

The main uses include the treatment of patients with renal failure, oncology, or rehabilitation of the residence in psychiatric hospitals. This offer remains highly fragmented, with a myriad of independent companies who are experiencing difficulties in the optimization of their services, and the hospital staff from having to manually manage each trip.

Ambler organizes the supply of health professionals in transportation (ambulance companies, light, medical vehicles and taxis) to meet both the most effective and efficient at the request of health care institutions. It simplifies the heavy administrative work involved in the management of non-emergency patient transport, which is a burden for the health personnel, as well as on the buyers and the teams in financial institutions.

Founded in 2018, Ambler has said that he has already convinced more than 200 private and public hospitals and 500 transport companies to switch to digital.

The company has raised €7.6 m in three parts, according to Crunchbase.

LEAVE A REPLY

Please enter your comment!
Please enter your name here